New Report Analyses Nitric Oxide - Based Drugs Market to 2015
Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has now added a new report which analyses the market for drugs where nitric oxide (NO) is involved in the mechanism of action.
(PRWEB) February 16, 2008
Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has now added a new report which analyses the market for drugs where nitric oxide (NO) is involved in the mechanism of action.
The report, "Nitric Oxide-Therapeutics, Markets and Companies", describes the latest role of NO in health and disease. The report identifies the various market segments for nitric oxide-based drugs and outlines the companies involved in developing them.
Authors of the report also forecast the worldwide pharmaceutical market to 2010 and 2015, keeping in perspective the market share of drugs where NO is involved in the mechanism of action. The various strategies for developing such drugs are discussed too.
Analysts say that Nitric oxide (NO) can generate free radicals as well as scavenge them. It also functions as a signaling molecule and has an important role in the pathogenesis of several diseases. A major focus of the report is delivery of NO by various technologies.
NO-based therapies are important in inflammatory disorders, cardiovascular diseases, erectile dysfunction, pain and neuroprotection. The first therapeutic use of NO was by inhaltion for acute respiratory distress syndrome (ARDS). NO-donors, NO-mimics and NOS modulators are described and compared along with developmental status.
The study compares various pharmacological approaches using SWOT (Strengths, Weaknesses, Opportunities, Threats) analysis. NO-based therapies are compared with conventional approaches and opportunities and methods for combination with modern biotechnology are described as well.
The report profiles 38 companies, of which 10 in particular, have a significant interest in NO-based therapeutics. It also contains information on the important collaborations in the area.
"Nitric Oxide-Therapeutics, Markets and Companies" is available in pdf format from Piribo. For more information, go to: http://www. piribo. com/publications/biotechnology/nitric_oxide. html (http://www. piribo. com/publications/biotechnology/nitric_oxide. html)
Piribo product ID: JAI017
About Piribo:
Piribo (http:www. piribo. com) is a UK-based independent online store supplying business information on the pharmaceutical and biotechnology industries. The website now carries over 7,000 English language titles including, market reports, studies and books and is the UK's largest online biopharma information store. Subscribers receive a free monthly newsletter and email alerts on new titles in their areas of interest. The company was established in 2004.
###